Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Exelixis Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
EXEL
Nasdaq
2834
https://www.exelixis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Exelixis Inc
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
- Sep 20th, 2023 6:15 pm
GSK's Momelotinib Gets FDA Nod for Myelofibrosis-Related Anemia
- Sep 18th, 2023 1:16 pm
4 Magnificent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
- Sep 16th, 2023 9:06 am
2 Top Biotech Stocks Defying the Bear Market
- Sep 15th, 2023 2:23 pm
Exelixis (EXEL) Gets Rights for Tumor Candidate From Insilico
- Sep 13th, 2023 3:23 pm
Exelixis and Insilico Medicine Enter into Exclusive Global License Agreement for ISM3091, a Potentially Best-in-Class USP1 Inhibitor
- Sep 13th, 2023 12:29 pm
J&J (JNJ) Seeks Approval for Bladder Cancer Drug in Europe
- Sep 11th, 2023 4:31 pm
Illumina (ILMN) Down 14.2% Since Last Earnings Report: Can It Rebound?
- Sep 8th, 2023 3:30 pm
Exelixis, Inc. (NASDAQ:EXEL) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
- Sep 8th, 2023 2:44 pm
J&J (JNJ) to End Pulmonary Hypertension Study on Opsumit
- Sep 7th, 2023 12:43 pm
AstraZeneca (AZN) Gets FDA CRL for Ultomiris in New Indication
- Sep 6th, 2023 1:33 pm
EXEL vs. ILMN: Which Stock Is the Better Value Option?
- Sep 5th, 2023 3:40 pm
Biogen's (BIIB) Stock Outperforms Industry YTD: Here's Why
- Sep 5th, 2023 1:40 pm
Exelixis (EXEL) Stock Gains 41.8% So Far in 2023: Here's Why
- Sep 4th, 2023 2:34 pm
Why Is Blueprint Medicines (BPMC) Down 2% Since Last Earnings Report?
- Sep 1st, 2023 3:31 pm
5 Biotech Stocks to Buy as New Drug Approvals Drive Industry Prospects
- Sep 1st, 2023 1:18 pm
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in September
- Aug 31st, 2023 8:05 pm
Why Is Exelixis (EXEL) Up 10.6% Since Last Earnings Report?
- Aug 31st, 2023 3:31 pm
The Top Healthcare Stocks to Buy With $100
- Aug 30th, 2023 12:00 pm
Top 5 High-Flying Mid-Cap Stocks Despite a Volatile August
- Aug 29th, 2023 12:02 pm
Scroll